Bruker Corporation (BRKR)

Return on total capital

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Earnings before interest and tax (EBIT) (ttm)	US$ in thousands	553,500	431,600	441,800	434,100	421,100	421,400	401,600	421,800	413,300	400,700	368,700	321,000	248,300	253,200	259,800	275,400	300,900	289,600	270,900	266,200
Long-term debt	US$ in thousands	1,160,300	1,098,600	1,122,500	1,109,000	1,200,500	1,136,800	1,171,000	1,205,400	1,221,800	717,500	721,100	715,800	842,300	828,200	924,200	914,800	812,800	518,500	493,900	212,300
Total stockholders’ equity	US$ in thousands	1,377,200	1,208,800	1,231,200	1,180,300	1,113,800	937,000	970,500	1,017,000	1,070,500	1,075,600	1,002,000	967,700	961,200	952,100	897,400	915,600	906,800	845,200	860,800	913,200
Return on total capital		21.81%	18.71%	18.77%	18.96%	18.20%	20.32%	18.75%	18.98%	18.03%	22.35%	21.40%	19.07%	13.77%	14.22%	14.26%	15.05%	17.50%	21.24%	20.00%	23.65%

December 31, 2023 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $553,500K ÷ ($1,160,300K + $1,377,200K)
= 21.81%

Bruker Corp's return on total capital has fluctuated over the past eight quarters, ranging from 18.27% to 21.76%. In general, the company has maintained a relatively stable performance in generating returns on capital during this period. The highest return on total capital was recorded in Q3 2022 at 21.76%, indicating efficient utilization of both debt and equity to generate profits. Conversely, the lowest return on total capital was observed in Q4 2023 at 18.27%. Despite the slight decrease in the most recent quarter, the company has demonstrated consistent profitability and effectiveness in utilizing its capital resources across the quarters analyzed. Further analysis and comparison with industry benchmarks may provide additional insights into Bruker Corp's financial performance.